Hydreight
Company
Hydreight develops 2 assets. Mostly peptide and protein or enzyme acting on Insulin/IGF-1 signalling, GLP1R and INSR.
- 2
- Assets
- Furthest stage
- Not known
- 0
- Trials
- 6
- Signals
Pipeline
2Oral needle-free sublingual/buccal delivery formulation of GLP-1 receptor agonist
Stage not known, Peptide, Insulin/IGF-1 signalling, GLP1R, Partner
Oral needle-free sublingual/buccal tablet formulation of insulin
Stage not known, Protein or enzyme, Insulin/IGF-1 signalling, INSR, Partner
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms3
- Signals6
- Similar companies6